香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 YUE YUEN INDUSTRIAL (HOLDINGS) LIMITED 裕元工業（ 集 團 ）有限公司 * （於百慕達註冊成立之有限公司） （股份代號：00551） 截至二零二五年六月三十日止六個月 未經審核中期業績 | 本集團財務摘要 | | | | | --- | --- | --- | --- | | | 截至六月三十日 | | | | | 止六個月 | | 增加╱（減少） | | | 二零二五年 | 二零二四年 | 百分比 | | （千美元） 營業收入 | 4,060,148 | 4,015,407 | 1.1% | | 本公司擁有人應佔經常 | | | | | （千美元） 性溢利 | 162,822 | 178,887 | (9.0)% | | 本公司擁有人應佔非經常 | | | | | 性溢利 （千美元） | 8,368 | 5,514 | 51.8% | | 本公司擁有人應佔 | | ...

Core Insights - The company, Yue Yuen Industrial Holdings Limited, reported a net operating income of approximately $667.5 million for July 2025, representing a year-on-year decrease of 1.9% [1] - For the first seven months, the cumulative net operating income was approximately $4.7295 billion, showing a year-on-year growth of 0.7% [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於百慕達註冊成立之有限公司） （股份代號：00551） 二零二五年七月之每月收益公告 按照國際會計準則，本公司被視為臺灣證交所上市公司寶成工業之附屬公司， 現時透過其附屬公司間接持有本公司之控制權益。寶成工業根據臺灣證券交易所規 例規定刊發每月收益公告。 由於寶成工業於今日公佈其若干綜合財務資料，故本公司根據上市規則第13.09(2)條及 證券及期貨條例第XIVA部刊發本公告，確保及時向投資者提供最新資料。 按照國際會計準則，裕元工業（集團）有限公司（「本公司」）被視為臺灣證券交易所股份 有限公司（「臺灣證交所」）上市公司寶成工業股份有限公司（「寶成工業」）之附屬公 司，現時透過其附屬公司間接持有本公司之控制權益。根據臺灣證券交易所股份有限 公司對上市公司資訊申報作業辦法（不時修訂）（「臺灣證券交易所規例」），寶成工 業須於每月刊發其前一個月份之綜合收益公告。 由於寶成工業於今日公佈上述每月綜合收益， ...

Group Overview - Yue Yuen Industrial's total revenue for 1H25 was US$4,060.1 million[12] - In 1H25, Athletic/Outdoor Shoes accounted for 53.6% of the business structure, Pou Sheng accounted for 31.1%, Casual Shoes & Sport Sandals accounted for 10.7%, and Soles, Components & Others accounted for 4.6%[11] Group Operation Highlights - Group revenue increased by 1.1% YoY to US$4,060.1 million in 1H25[41] - Profit attributable to owners decreased slightly by 0.3% YoY to US$155.0 million[41] - Manufacturing revenue increased by 6.2% YoY to US$2,797.9 million in 1H25[41] - Retail revenue decreased by 8.3% YoY to RMB 9,159 million in 1H25[41] - Interim dividend remained flat YoY at HK$0.40 per share, with a payout ratio of 48%[41] - Shoe volume increased by 5.0% YoY to 126.7 million pairs in 1H25[39] - Average Selling Price (ASP) increased by 3.2% YoY to US$20.61 per pair in 1H25[39] Manufacturing Business - Manufacturing revenue increased by 6.2% YoY to US$2,797.98 million in 1H25[64] - Manufacturing gross profit margin decreased by 1.4 percentage points YoY to 17.7% in 1H25[64] - Manufacturing operating profit margin decreased by 1.3 percentage points YoY to 5.9% in 1H25[64] Retail Business - Pou Sheng - Pou Sheng's revenue decreased by 8.3% YoY to RMB 9,159 million in 1H25[41] - Online contribution reached a historical high, accounting for 33% of total sales, a 16% YoY increase[97] - Pou Sheng's number of employees decreased by 7% YoY from 20,700 to 19,200[108]

Group 1 - The article provides an overview of the investment activities of Hong Kong-listed companies on August 11, 2025, including new stock activities, earnings announcements, shareholder meetings, and dividend distributions [1] Group 2 - New stock activities include companies such as ZhiNuo Pharmaceutical-B (currently in the IPO process) and Zhonghui Biotechnology-B (listing date) [1] - Earnings announcements are scheduled for companies like Baosheng International, Yuanyuan Group, and Kang Shifu Holdings among others [1] - Shareholder meetings will be held for companies including Huatai Textile, Shandong Gold, and Sichuan Chengyu Expressway [1] - Dividend distributions are noted for companies like Jianbei Miao Miao and Kangnait Optical, with specific ex-dividend and payment dates mentioned [1]

Core Viewpoint - The report from Credit Lyonnais indicates that the stock price of Yue Yuen Industrial Holdings has rebounded by 33% since the end of April, but challenges are anticipated in the upcoming quarters [1] Group 1: Financial Performance - The company is expected to see a 1% year-on-year increase in sales for Q2, while net profit is projected to decline by 10% due to pressures on gross margins from order fluctuations, a weak offline retail environment, and adverse foreign exchange factors [1] - The forecast for sales from 2025 to 2027 has been reduced by 4%, and net profit forecasts have been cut by 19% to 23% to reflect the gross margin pressures from manufacturing and retail operations this year [1] Group 2: Market Outlook - The market is believed to have recognized the challenges that will arise in Q3, with a focus on the order outlook, utilization trends, and retail profitability for Q4 as key indicators for the stock [1] - The target price for Yue Yuen has been lowered from HKD 19 to HKD 16, while maintaining an "outperform" rating, with a projected dividend yield of 10% for 2026 [1]

Core Insights - Adidas reported a 7% year-on-year revenue growth for FY2025H1, reaching €12.105 billion, with a net profit increase of 121% to €798 million [4] - The brand's revenue growth was 14% on a currency-neutral basis, with all regional markets achieving double-digit growth [4] - The company maintains its full-year guidance, expecting high single-digit revenue growth on a currency-neutral basis for FY2025, with double-digit growth for the Adidas brand [4] Market Trends - The domestic market indices showed positive performance, with the Shanghai Composite Index closing at 3,617.60, up 0.96% [3] - The textile and apparel sector experienced a decline of 2.14% this week, underperforming the broader market [5] - Retail sales of sports and entertainment products grew significantly, with a 22.2% year-on-year increase in the first half of 2025 [5] Industry Dynamics - The Chinese gold consumption in the first half of 2025 was 505.205 tons, a decrease of 3.54% year-on-year, with jewelry consumption dropping by 26% [5] - The pharmaceutical industry is seeing advancements in innovative drugs, particularly in obesity treatments with GLP-1 and Amylin therapies showing promising results in clinical trials [8][11] - In the biopharmaceutical sector, ADC drugs for lung cancer are demonstrating significant efficacy, with several products showing improved outcomes in clinical trials [10][12]

Group 1 - The core index of the CSI Hong Kong Stock Connect Textile, Apparel, and Jewelry Composite Index is reported at 1922.06 points, with a recent one-month decline of 4.00%, a three-month increase of 9.13%, and a year-to-date increase of 13.10% [1] - The index is compiled based on the classification standards of the CSI industry, reflecting the overall performance of different industry securities within the Hong Kong Stock Connect [1] - The top ten weighted stocks in the index include Li Ning (15.18%), Shenzhou International (15.11%), Anta Sports (14.03%), Lao Pu Gold (12.04%), Chow Tai Fook (9.28%), Samsonite (7.96%), Bosideng (7.29%), Jiu Xing Holdings (3.71%), Yue Yuen Industrial (3.57%), and Xtep International (3.4%) [1] Group 2 - The industry composition of the index shows that apparel accounts for 57.20%, jewelry and luxury goods account for 24.16%, and footwear and accessories account for 18.65% [2] - The index sample is adjusted biannually, with adjustments implemented on the next trading day following the second Friday of June and December each year [2] - In the event of special circumstances affecting the index sample, such as delisting or mergers, the sample will be adjusted accordingly [2]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [4][13][15]. Core Views - Yuanyuan Group is the world's largest sports shoe manufacturer, with a diversified brand client portfolio and production bases. The company is expected to achieve sustainable growth in its manufacturing business following the end of the overseas destocking cycle and diversified capacity layout. The retail business is anticipated to grow steadily through vertical market development and new brand contributions. The projected net profits for 2025-2027 are $390 million, $430 million, and $480 million, respectively, with corresponding PE ratios of 6X, 6X, and 5X, indicating a low valuation level [4][13][20]. Company Overview - Yuanyuan Group, established in 1988, operates in OEM/ODM shoe manufacturing and sports apparel retail. In 2024, the revenue and net profit contributions from manufacturing and retail are expected to be 69%/84% and 31%/16%, respectively, with total revenue of $8.18 billion and net profit of $390 million. The company has established long-term partnerships with international brands such as Nike, Adidas, Asics, and New Balance, with production bases in Vietnam, Indonesia, and China [4][10][20]. Manufacturing Business - The manufacturing segment has a revenue scale superior to comparable companies, but its growth rate has been relatively poor, with a CAGR of -1.3% from 2019 to 2024. However, improvements are expected in 2024 due to normalized orders and capacity expansion in India. The company has room for cost improvement, as its net profit margin remains lower than peers despite recent operational optimizations [11][12][51]. Retail Business - The retail segment shows performance disparities, with 宝胜国际 and 滔搏 facing challenges. In 2024, 宝胜国际's revenue is projected to decline by 8% to $2.845 billion, while its net profit margin is expected to improve slightly to 2.7%. The company is focusing on stabilizing retail discounts and improving profit margins to achieve quality profit growth [11][12][51]. Market Outlook - The sports shoe and apparel market is experiencing high demand, driven by increased awareness of physical fitness and the development of sports initiatives. The industry is characterized by high concentration, with market share gradually shifting towards leading brands. The manufacturing side benefits from high entry barriers, while the retail side is expected to grow steadily through multi-channel operations and brand matrix expansion [12][20][41].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: Yue Yuen Industrial (Holdings) Limited 裕元工業(集團)有限公司（於百慕達註冊成立之有限公司） 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00551 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.25 HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | ...